.beta.-glucan treatment of upper respiratory tract infection...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/716 (2006.01) A61P 11/00 (2006.01)

Patent

CA 2700922

Studies involving placebo-controlled, double-blinded designs to evaluate the effect of beta-glucan compositions on upper-respiratory tract infections and psychological wellness were carried out. During the course of the reporting periods of these studies, subjects in the treatment groups reported fewer URTI symptoms, better overall health and a more positive psychological assessment based on a POMS survey.

Il a été réalisé des études impliquant des protocoles en double aveugle contre un placebo pour évaluer l'effet de compositions à base de bêta-glucane sur des infections des voies respiratoires supérieures et le bien-être psychologique. Au cours de l'avancée des périodes de rapport de ces études, les sujets dans les groupes de traitement ont rapporté moins de symptômes d'infection des voies respiratoires supérieures, une meilleure santé globale et une estimation psychologique plus positive basée sur une enquête POMS (Profile of Mood States).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

.beta.-glucan treatment of upper respiratory tract infection... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with .beta.-glucan treatment of upper respiratory tract infection..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-glucan treatment of upper respiratory tract infection... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1656391

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.